In the latest trading session, 2.41 million ZyVersa Therapeutics Inc (NASDAQ:ZVSA) shares changed hands as the company’s beta touched 0.64. With the company’s most recent per share price at $2.20 changed hands at -$0.1 or -4.34% at last look, the market valuation stands at $2.35M. ZVSA’s current price is a discount, trading about -1893.18% off its 52-week high of $43.85. The share price had its 52-week low at $1.90, which suggests the last value was 13.64% up since then. When we look at ZyVersa Therapeutics Inc’s average trading volume, we note the 10-day average is 0.25 million shares, with the 3-month average coming to 105.82K.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA was in red as seen in intraday trades today. With action -4.34%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -75.55%, with the 5-day performance at -4.34% in the red. However, in the 30-day time frame, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is 1.86% up. Looking at the short shares, we see there were 23829.0 shares sold at short interest cover period of 0.32 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts
Data shows that the ZyVersa Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -60.90% over the past 6 months, a 97.65% in annual growth rate that is considerably higher than the industry average of 17.20%.
ZVSA Dividends
ZyVersa Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Aug-09.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.61% of ZyVersa Therapeutics Inc shares while 5.18% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 5.21%.
Among Mutual Funds, the top two as of Aug 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 7.08 shares estimated at $16210.0 under it, the former controlled 0.66% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.00% of the shares, roughly 50.0 shares worth around $114.0.
